Vivos Therapeutics, Inc. (VVOS) News
Track canonical SquawkNews coverage tagged to VVOS, Vivos Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 17 indexed stories across 11 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
VVOS debt reduction announced by Vivos Therapeutics
Vivos Therapeutics (VVOS) announced material debt reduction.
EQUITY | Sep 08, 2026, 12:45 PM UTC
M
Vivos Therapeutics swaps $2.86M Streeterville notes for up to 11.45M shares
Vivos Therapeutics entered twelve exchange agreements effective Aug 31, 2026 to convert $2,861,270 of partitioned Streeterville notes into up to 11,445,080 common shares at prices at or above Nasdaq minimums.
EQUITY | Sep 08, 2026, 10:04 AM UTC
L
Vivos Therapeutics to present at 2026 Moody Capital Solutions conference
Vivos Therapeutics, Inc. (VVOS) said it will present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference.
EQUITY | Sep 01, 2026, 12:06 PM UTC
L
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASD
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (SGCC)
EQUITY | Aug 29, 2026, 01:22 PM UTC
L
VVOS to launch regional sleep testing and treatment center
Vivos Therapeutics and South Palm Cardiovascular Associates signed definitive agreements to launch a regional sleep testing and treatment center.
EQUITY | Aug 28, 2026, 12:47 PM UTC
L
Vivos Therapeutics (VVOS) reports record new patient referrals
Vivos Therapeutics reports record new patient referrals at its Nevada Sleep & Airway Medicine Centers, per TradeXchange Newsdesk, with no additional figures or catalyst provided.
EQUITY | Aug 25, 2026, 12:45 PM UTC
L
Vivos Therapeutics opens new sleep testing and treatment facility in Nevada
Vivos Therapeutics says it has opened a new sleep testing and treatment facility in Nevada to meet growing patient demand for sleep apnea testing and treatment.
EQUITY | Aug 20, 2026, 02:24 PM UTC
L
Vivos Therapeutics reports Q2 2026 financial results
Vivos Therapeutics (VVOS) reports second quarter 2026 financial results and provides an operational update, according to TradeXchange Newsdesk.
EARNINGS | Aug 14, 2026, 08:28 PM UTC
L
Vivos Therapeutics schedules Q2 2026 results release
Vivos Therapeutics (VVOS) schedules the release of its second quarter 2026 financial results and a conference call, per the company’s announced timing.
EARNINGS | Aug 14, 2026, 12:45 PM UTC
M
Vivos Therapeutics Issues New US Patent
Vivos Therapeutics issues new US patent for oral device
EQUITY | Aug 05, 2026, 12:31 PM UTC
H
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of Arista Networks Inc (NYSE: ANET ) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued strong third-quarter guidance. Arista Networks re
EARNINGS | Aug 05, 2026, 08:57 AM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC
L
Vivos Therapeutics Announces Its Treatment With ITS FDA-Cleared Vida Oral Appliance Demonstrates Enhancement In Insomnia Severity In 100% Of
Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS ), a leading medical device and healthcare services company focused on the treatment of breathing‑related sleep disorders such as obstructive sleep apnea
REGULATION | Jun 30, 2026, 12:47 PM UTC
M
Healthcare Stocks Move
Multiple healthcare stocks are moving in Tuesday's after-market session, with some rising and others falling
EQUITY | Jun 23, 2026, 09:09 PM UTC
M
VVOS Extends Financing Deal
Vivos Therapeutics extends Streeterville financing agreement through August 31, reaffirming plan to convert up to $4.5M debt into stock
EQUITY | Jun 22, 2026, 12:44 PM UTC
M
VVOS Extends Financing Deal
VVOS extends strategic financing deal through August 31, reaffirming plan to convert up to $4.5M debt into preferred and common stock
EQUITY | Jun 22, 2026, 12:40 PM UTC
L
VVOS Extends Financing Agreement
VVOS - Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
EQUITY | Jun 22, 2026, 12:31 PM UTC